| Filed On | Filing |
|---|---|
| 10 Nov 2022 |
Form 3: Swain Sandra M, Director
No securities owned |
| 10 Nov 2022 |
Form 3: Epstein David R, Director
No securities owned |
| 18 Aug 2020 |
Form 3: Love Ted W, Director
No securities owned |
| 21 Apr 2020 |
Form 3: Romp Charles R, EVP, Commercial
Holds 55,771 shares of Common Stock |
| 22 May 2019 |
Form 3: Taylor Robin G, Chief Commercial Officer
No securities owned |
| 31 May 2018 |
Form 3: Dansey Roger D, Chief Medical Officer
No securities owned |
| 15 Mar 2018 |
Form 3: Seth Alpna, Director
No securities owned |
| 17 Feb 2015 |
Form 3: Cline Darren S, SVP, Commercial
Holds 40,635 shares of Common Stock |
| 11 Dec 2014 |
Form 3: FBB3 Llc, Director
Holds 12,678 shares of Common Stock |
| 03 Dec 2014 |
Form 3: Liu Jean I, EVP, Legal Affairs & GC
No securities owned |
| 14 Jan 2014 |
Form 3: Orwin John A, Director
No securities owned |
| 11 Oct 2013 |
Form 3: Drachman Jonathan G, CMO & EVP, R & D
Holds 43,012 shares of Common Stock |
| 11 Jul 2013 |
Form 3: Baker Bros. Advisors (GP) Llc, Director
No securities owned |
| 21 May 2013 |
Form 3: Baker Brothers Life Sciences Lp, Director
Holds 15,131,223 shares of Common Stock |
| 21 May 2013 |
Form 3: 667, L.p., Director
Holds 3,868,576 shares of Common Stock |
| 21 May 2013 |
Form 3: 14159, L.p., Director
Holds 323,148 shares of Common Stock |
| 18 Jun 2012 |
Form 3: FBB2 Llc, Director
Holds 18,243 shares of Common Stock |
| 23 Apr 2012 |
Form 3: Baker Bros Advisors Llc, Director
Holds 0 shares of Common Stock |
| 21 Mar 2012 |
Form 3: Simonian Nancy A, Director
No securities owned |
| 05 Mar 2012 |
Form 3: Boerner Christopher S., SVP, Commercial
Holds 7,348 shares of Common Stock |
Loading...